Close Menu

Columbia

NEW YORK (GenomeWeb) – In Nature Genetics, an international team led by investigators at Columbia and Yale Universities unveiled previously unknown risk loci for IgA nephropathy, a kidney condi

NEW YORK (GenomeWeb) – The Regeneron Genetics Center, a wholly-owned subsidiary of Regeneron Pharmaceuticals, has partnered with Columbia University Medical Center, the Clinic for Special Children, and Baylor College of Medicine to study a variety of Mendelian diseases.

NEW YORK (GenomeWeb) – Cancer Genetics today announced a collaboration with Columbia University researchers to identify more accurate diagnostic and prognostic biomarkers for myelodysplastic syndromes.

Nikon Research Corporation of America has been awarded

NEW YORK (GenomeWeb) – By sequencing the complete genomes of 128 people of Ashkenazi Jewish ancestry, a team of researchers from New York, Israel, and elsewhere developed a database of variants in the population.

NEW YORK (GenomeWeb) – A clinical cancer whole-exome and transcriptome sequencing test recently launched by Columbia University's Laboratory of Personalized Genomic Medicine promises to impact the treatment of cancer patients.

NEW YORK (GenomeWeb) — After more than three years offering clinical whole exome sequencing for pediatric and adult patients suspected of having rare genetic disorders, clinicians from Columbia University Medical Center have concluded that the approach is a feasible, useful, and timely option for

NEW YORK (GenomeWeb) – In Nature Genetics, researchers from Sweden, the UK, and the US explored the potential risks of losing the Y chromosome from a subset of cells circulating in peripheral bl

NEW YORK (GenomeWeb News) – The Plasmodium vivax parasite species behind most human malaria cases in Asia and Latin America can be traced back to Africa, where some ape species are still frequently afflicted with the parasite, according to a Nature Communications

For a little over a year, doctors at Columbia University have been testing clinical exome sequencing to help diagnose patients with suspected genetic disorders of unknown origin.

Pages

A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.